↓ Skip to main content

Bone marrow mesenchymal stem cells suppress metastatic tumor development in mouse by modulating immune system

Overview of attention for article published in Stem Cell Research & Therapy, March 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

patent
2 patents

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
39 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Bone marrow mesenchymal stem cells suppress metastatic tumor development in mouse by modulating immune system
Published in
Stem Cell Research & Therapy, March 2015
DOI 10.1186/s13287-015-0039-8
Pubmed ID
Authors

Lei Zhang, Xiao San Su, Jun Song Ye, Yi Yin Wang, Zheng Guan, Yan Feng Yin

Abstract

Bone marrow mesenchymal stem cells (BMSCs) have been studied extensively because of their potential use in clinical therapy, regenerative medicine, and tissue engineering. However, their application in tumor therapy remains yet in preclinical stage because of the distinct results from different researches and vagueness of their functional mechanism. In this study, the influence of BMSCs on tumor growth was observed and the potential mechanism was investigated. Two animal models, H22 ascitogenous hepatoma in BALb/c mouse and B16-F10 pulmonary metastatic melanoma in C57 mouse, were adopted in experience in vivo and treated with BMSCs by intravenous injection. The percentage of Gr-1(+)CD11b(+) myeloid-derived suppressor cells (MDSCs) and IFN-γ(+) T cells were observed in peripheral blood (PB) and bone marrow (BM) by Flow Cytometry. BMSCs were co-cultured in vitro with tumor cells and MDSCs in a tumor conditioned medium separately in order to illustrate the mechanism. Our results demonstrated that BMSCs treatment caused a delayed tumor growth and a prolonged survival in both tumor models, the homing fraction of BMSCs in BM was 2% - 5% in 24-72 hours after transfusion and the percentage of Gr-1(+)CD11b(+) MDSCs was downregulated in peripheral blood and BM. Meanwhile, IFN-γ(+) T lymphocytes in PB increased. In vitro co-culture showed that BMSCs inhibited the induction and proliferation of MDSCs in tumor conditioned medium, whereas they didn't affect the proliferation of B16-F10 and H22 cells by in vitro co-culture. Both in vivo and in vitro results showed that BMSCs have a systemic suppressive effect on MDSCs. Our data suggest that BMSCs has suppressive effect on tumor and is feasible to be applied in cancer treatment. BMSCs inhibiting MDSCs induction and proliferation is likely one of the mechanism.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Unknown 38 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 21%
Researcher 8 21%
Student > Bachelor 6 15%
Student > Master 4 10%
Other 2 5%
Other 6 15%
Unknown 5 13%
Readers by discipline Count As %
Medicine and Dentistry 12 31%
Agricultural and Biological Sciences 12 31%
Biochemistry, Genetics and Molecular Biology 3 8%
Immunology and Microbiology 2 5%
Nursing and Health Professions 1 3%
Other 4 10%
Unknown 5 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 October 2020.
All research outputs
#4,698,399
of 22,799,071 outputs
Outputs from Stem Cell Research & Therapy
#481
of 2,418 outputs
Outputs of similar age
#59,726
of 263,360 outputs
Outputs of similar age from Stem Cell Research & Therapy
#16
of 64 outputs
Altmetric has tracked 22,799,071 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,418 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 263,360 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 64 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.